EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Comparing Outcomes of Moyamoya Disease and Moyamoya Syndrome in a Real‐World Scenario: A Cohort Study

Xiao-Peng Wang iD, Jing-Jie Li, Qian-Nan Wang, Gan Gao, Dan Yu, Qian Zhang, Si-Meng Liu, Min-Jie Wang, Xiang-Yang Bao, Lian Duan iD

CNS Neuroscience & Therapeutics · 2024-12 · 30 (12)

DOI: 10.1111/cns.70165 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.12.2024. Verfasst von Xiao-Peng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Moyamoya Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Moyamoya disease (MMD) and moyamoya syndrome (MMS) are rare cerebrovascular conditions with unclear distinctions in clinical presentation and prognosis.

Aim

This study assessed potential differences between MMD and MMS patients using real‐world data on clinical manifestations, surgical outcomes, and stroke risk factors.

Methods

This multicenter, retrospective cohort study examined patients with MMD or MMS treated at three tertiary academic hospitals in China, with a mean follow‐up of 11.2 ± 3.1 years. Clinical differences were compared between MMD and MMS, and postoperative cerebrovascular events were compared between patients who underwent surgery and those with conservative management. Primary outcomes were postoperative ischemic and hemorrhagic strokes. Risk factors were evaluated via multivariate Cox regression analysis.

Results

Of the 2565 patients, 2349 had MMD and 216 had MMS. After 1:1 propensity‐score matching, no significant differences were observed between these two cohorts. Surgical patients had fewer cerebrovascular events than those who received conservative treatment (HR, 0.487; 95% CI, 0.334–0.711; p < 0.001). Preadmission modified Rankin scale scores > 2 (HR, 3.139; 95% CI, 1.254–7.857; p = 0.015) and periprocedural complications (HR, 8.666; 95% CI, 3.476–21.604; p < 0.001) were independent stroke risk factors in patients with MMD. Periprocedural complications (HR, 31.807; 95% CI, 10.916–92.684; p < 0.001) increased stroke risk in patients with MMS.

Conclusions

This real‐world study revealed substantial clinical overlap between MMD and MMS. Both groups derived significant benefits from surgical revascularization, suggesting distinction may not be necessary to guide surgical management decisions. Optimizing preoperative status and preventing periprocedural complications may improve outcomes in these rare cerebrovascular conditions. Trial Registration This study has been registered in the Chinese Clinical trial registry (registration number: ChiCTR2200064160)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Moyamoya DiseaseHumansMaleFemaleRetrospective StudiesAdultMiddle AgedCohort StudiesTreatment OutcomeAdolescentPostoperative ComplicationsChinaFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

moyamoya diseasemoyamoya syndromemulticenterpropensity‐score matchingreal‐world studyrevascularization

Autor:innen und Institutionen

  • Senior Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Medical School of Chinese PLA, Beijing, China.
  • Senior Department of Neurosurgery, The Eighth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Senior Department of Neurosurgery, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Xiao-Peng Wang, Lian Duan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, X. P., Li, J. J., Wang, Q. N., Gao, G., Yu, D., Zhang, Q., Liu, S. M., Wang, M. J., Bao, X. Y., & Duan, L. (2024). Comparing Outcomes of Moyamoya Disease and Moyamoya Syndrome in a Real‐World Scenario: A Cohort Study. CNS Neuroscience & Therapeutics, 30(12). https://doi.org/10.1111/cns.70165

Vancouver

Wang XP, Li JJ, Wang QN, Gao G, Yu D, Zhang Q, et al. Comparing Outcomes of Moyamoya Disease and Moyamoya Syndrome in a Real‐World Scenario: A Cohort Study. CNS Neuroscience & Therapeutics. 2024;30(12). doi:10.1111/cns.70165

BibTeX
@article{Wang2024,
  author = {Wang, Xiao-Peng and Li, Jing-Jie and Wang, Qian-Nan and Gao, Gan and Yu, Dan and Zhang, Qian and Liu, Si-Meng and Wang, Min-Jie and Bao, Xiang-Yang and Duan, Lian},
  title = {Comparing Outcomes of Moyamoya Disease and Moyamoya Syndrome in a Real‐World Scenario: A Cohort Study},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {12},
  doi = {10.1111/cns.70165}
}
Kostenlos starten →